The first scientific study to examine the effects of digital therapy on pulmonary rehabilitation clinically validates the efficacy of the Kaia healthcare offering
NEW YORK, June 08, 2022– (BUSINESS WIRE) – Kaia Health, the largest global digital therapy company with a mission to make high-quality, evidence-based therapies accessible to anyone at any time, today announced the availability of the virtual offering clinically validated by the company for the obstructive chronic rehabilitation of pulmonary diseases (COPD). The launch in North America builds on the company’s already established success in research, development and application launch in Germany and the promising results of a randomized controlled trial (RCT) recently published in Thorax.
COPD refers to a group of conditions that cause blockage of airflow and breathing problems, including emphysema and chronic bronchitis. According to the Centers for Disease Control and Prevention, nearly 15.7 million Americans (6.4%) reported being diagnosed with COPD, which was the fourth leading cause of death in the United States in 2018. Although there is no cure. For the condition, COPD can be treated using digital therapeutic pulmonary rehabilitation (PR) solutions such as those developed by Kaia Health. There is also clinical evidence to suggest that PR can be used to address the lengthy symptoms of COVID-19.
PR is considered important for COPD patients to improve their quality of life and exercise capacity, but in many cases it is difficult to access. Currently, PR is offered in-person in outpatient clinics, but is typically limited to metropolitan areas. A 2021 study by the University of Alabama Pulmonary Center found that the average distance between COPD patients and their nearest PR center was, on average, 8.6 miles in metropolitan areas, 20.0 miles in areas. micro or suburban areas and 26.6 miles in small urban / rural areas. By offering patients an easily accessible virtual PR solution, Kaia Health is improving access to care and lowering the barrier to integrating exercise into patients’ lives. At the same time, this provides a training program that helps patients manage their COPD condition and maintain their physical activity levels.
The Kaia COPD app can also significantly reduce costs for taxpayers. According to a study published in the International Journal of Chronic Obstructive Pulmonary Disease, Total annual health care costs were 3 times higher for COPD patients than for patients without, with direct medical costs associated with the condition of $ 32 billion and indirect costs of $ 20.4 billion.
Based on the Kaia Health digital therapy platform, the Kaia Health COPD app digitizes and delivers affordable, affordable physical PR, considered the gold standard in COPD, right to patients’ homes on their smartphones. It is available anytime, anywhere, without requiring hospitalization or a visit to a health facility.
“As the largest global digital therapy company in all conditions, Kaia Health has a mission to break down barriers and provide high-quality, affordable care that is accessible to all. I am so proud that we have been able to expand our our digital therapy platform to now help patients living with COPD and those dealing with musculoskeletal problems, “said Nigel Ohrenstein, president of Kaia Health. “Maintaining physical activity in COPD patients has been shown to reduce readmissions by increasing overall survival rates. Today we are leading the industry by offering a new treatment option that is improving patients’ health and quality of life.” .
Kaia Health’s COPD app is a market leader in comprehensive digital pulmonary rehabilitation and was recently clinically validated via a physician-led RCT from the Rehabilitation Centers of Zurich and the University of Marburg. The scientific study, the first of its kind, looked at how using Kaia Health affects physical activity after hospital treatment. As a result, the researchers found that with Kaia Health, improvements in the patient’s health status from hospital rehabilitation were maintained at much greater rates than in the control group for the entire 6-month study duration. The study also showed that using Kaia Health significantly reduces the overall severity of symptoms.
To learn more about how Kaia Health can enable healthcare organizations to minimize the impact of chronic conditions, including COPD and musculoskeletal pain, while reducing medical spending, visit: https://kaiahealth.com/ to schedule a demo or contact directly at [email protected].
About Kaia Salute
Kaia Health is the largest digital therapy company in the world creating accessible, evidence-based treatments for a range of conditions, including MSK pain and COPD. Kaia Health covers 60 million lives worldwide and its clinically proven motion analytics capability is transforming and democratizing healthcare through technology that patients can access anytime, anywhere, with the camera of their smartphone or tablet. . Kaia Health is the most clinically validated digital MSK provider and its motion analysis technology is as accurate as physiotherapists in suggesting exercise corrections, resulting in equal care regardless of BMI, age, gender or location. Kaia Health is a member of the Digital Therapeutics Alliance (DTA) and has offices in New York and Munich. Learn more at www.kaiahealth.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220608005747/en/